Get startedLog in
    Picture of Pfizer logo

    PFE — Pfizer News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareConservativeLarge CapSuper Stock
    All News

    Pfizer's prostate cancer drug combination gets FDA priority review

    Picture of Pfizer logoPfizer
    22/07/2026 21:35
    Pfizer's prostate cancer drug combination gets FDA priority review
    July 22 (Reuters) - Pfizer PFE.N said on Wednesday the U.S. Food and Drug Administration has granted priority review to its application seeking to expand approval of its prostate cancer treatment combination.

     (Reporting by Padmanabhan Ananthan in Bengaluru; Editing by Shailesh Kuber)
     ((Padmanabhan.Ananthan@thomsonreuters.com;))

    Recent news on Pfizer

    See all news